{"1": ["ARTICLE 1 Definitions", {}], "2": ["ARTICLE 2 Licenses", {}], "3": ["ARTICLE 3 Development", {}], "4": ["ARTICLE 4 Regulatory", {}], "5": ["ARTICLE 5 Commercialization", {}], "6": ["ARTICLE 6 Supply", {}], "7": ["ARTICLE 7 Payments", {}], "8": ["ARTICLE 8 Payment; Records; Audits", {}], "9": ["ARTICLE 9 Intellectual Property Matters", {}], "10": ["ARTICLE 10 Representations, Warranties and Covenants; Compliance", {}], "11": ["ARTICLE 11 Indemnification", {}], "12": ["ARTICLE 12 Confidentiality", {}], "13": ["ARTICLE 13 Term and Termination", {}], "14": ["ARTICLE 14 Effects of Expiration Or Termination", {}], "15": ["ARTICLE 15 Miscellaneous", {}], "16": ["Schedule  1.10  Antibody 50", {}], "17": ["Schedule  1.79  Xencor General Patents 51", {}], "18": ["Schedule  1.81  Xencor Product Specific Patents 52", {}], "19": ["Schedule  2.7  Xencor Know-How, Regulatory Materials, and Regulatory Data 53", {}], "20": ["Schedule  6.1  Initial Product Supply 54", {}], "21": ["Schedule 1 0.2 .6 Exceptions 55", {}], "22": ["Schedule 1 2.2  Initial Press Release 56", {}]}